Drug intelligence / Profile preview

rhubarb + sodium bicarbonate

Development stage: Unknown
Lead developer: Fusen Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Rhubarb + sodium bicarbonate is a combination oral tablet manufactured by Sichuan Sunnyhope (Sichuan Shenghe Pharmaceutical). It is a traditional pharmaceutical preparation used primarily for digestive disorders. The rhubarb component contains anthraquinone derivatives like emodin and rhein, which function as a bitter stomachic to stimulate gastric secretion and as a stimulant laxative to promote bowel movements. Sodium bicarbonate acts as an antacid, neutralizing excess gastric acid to alleviate symptoms of hyperacidity. The combination is indicated for the treatment of indigestion, loss of appetite, and constipation associated with gastric acid imbalance.

Other names: Dahuang Tansuanqingna PianRhubarb and Sodium Bicarbonate Tablets

Beyond the preview

Go deeper on rhubarb + sodium bicarbonate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on rhubarb + sodium bicarbonate.

Explore the full profile